Positive Survival Trend Seen In Phase I Study Of Temsirolimus, Capecitabine

A phase I clinical trial examining the safety of combining temsirolimus and capecitabine in advanced malignancies suggests the two agents can be given safely to patients. In addition, the Georgetown Lombardi Comprehensive Cancer Center researchers conducting the study in cancer patients whose tumors have resisted multiple treatments say the combination demonstrates "promising evidence" of disease control and should be studied in a phase II trial...

Source: http://feedproxy.google.com/~r/mnt/healthnews/~3/bYTqwtOVS3o/245512.php

rehab sport sport medical